SCYX
Scynexis Inc
NASDAQ · Pharmaceuticals
$0.76
+0.07 (+9.94%)
Open$0.71
Previous Close$0.69
Day High$0.78
Day Low$0.70
52W High$8.28
52W Low$4.38
Volume—
Avg Volume493.4K
Market Cap31.85M
P/E Ratio12.63
EPS$0.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+969.8% upside
Current
$0.76
$0.76
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 10.03M | 9.68M | 11.00M |
| Net Income | 2.85M | 2.71M | 2.47M |
| Profit Margin | 28.5% | 28.0% | 22.5% |
| EBITDA | 3.19M | 3.39M | 3.79M |
| Free Cash Flow | 2.29M | 1.90M | 2.29M |
| Rev Growth | +19.6% | +15.5% | +17.7% |
| Debt/Equity | 0.17 | 0.16 | 0.17 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |